Z-1523-2021 Class II Ongoing
FDA device recall Z-1523-2021 was initiated by Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) on April 6, 2021 and is designated Class II. Reason for recall: There is a SmartSync software issue that results in an overestimation in the displayed longevity of these devices during an approximate 6-month window of time before the device triggers its Recommende… The recall status is ongoing. Affected quantity: 45,411 devices.
Recall Details
- Product Type
- Devices
- Report Date
- May 12, 2021
- Initiation Date
- April 6, 2021
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 45,411 devices
Product Description
CRT-P Quad Models (CRT-Ps): a. Percepta CRT-P MRI: W1TR01, W1TR04, W4TR01, W4TR04 b. Serena CRT-P MRI: W1TR02, W1TR05, W4TR02, W4TR05 c. Solara CRT-P MRI: W1TR03, W1TR06, W4TR03, W4TR06. implantable medical devices used to treat arrhythmias related to bradycardia, and cardiac resynchronization therapy (CRT)
Reason for Recall
There is a SmartSync software issue that results in an overestimation in the displayed longevity of these devices during an approximate 6-month window of time before the device triggers its Recommended Replacement Time (RRT).
Distribution Pattern
Worldwide
Code Information
all serial numbers